Research Consortium Receives $1.6M to Develop Stem Cell Therapies for Skin Diseases
The Epidermolysis Bullosa iPS Cell Consortium has received $1.6 million in funding to develop stem cell-based therapies for people with inherited skin diseases such as epidermolysis bullosa (EB). A grant from the National Institutes of Health (NIH) 21st Century Cures Act provided $800,000, which was quickly matched by…